GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (OTCPK:SDMHF) » Definitions » Cyclically Adjusted PB Ratio

SDMHF (Sartorius Stedim Biotech) Cyclically Adjusted PB Ratio : 9.74 (As of May. 31, 2025)


View and export this data going back to . Start your Free Trial

What is Sartorius Stedim Biotech Cyclically Adjusted PB Ratio?

As of today (2025-05-31), Sartorius Stedim Biotech's current share price is $216.65. Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $22.24. Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio for today is 9.74.

The historical rank and industry rank for Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

SDMHF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 8.18   Med: 16.54   Max: 37.75
Current: 9.6

During the past years, Sartorius Stedim Biotech's highest Cyclically Adjusted PB Ratio was 37.75. The lowest was 8.18. And the median was 16.54.

SDMHF's Cyclically Adjusted PB Ratio is ranked worse than
93.15% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.82 vs SDMHF: 9.60

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted book value per share data for the three months ended in Mar. 2025 was $44.140. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $22.24 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Chart

Sartorius Stedim Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 25.43 16.24 10.02

Sartorius Stedim Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.72 9.10 10.55 10.02 9.17

Competitive Comparison of Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio falls into.


;
;

Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=216.65/22.24
=9.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Sartorius Stedim Biotech's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=44.14/127.7792*127.7792
=44.140

Current CPI (Mar. 2025) = 127.7792.

Sartorius Stedim Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201306 5.798 98.516 7.520
201312 6.408 99.356 8.241
201406 6.482 99.543 8.321
201412 7.124 99.543 9.145
201506 7.089 100.417 9.021
201512 7.578 99.717 9.711
201606 8.178 100.717 10.375
201612 8.674 101.217 10.950
201706 9.712 102.117 12.153
201709 0.000 102.717 0.000
201712 11.195 102.617 13.940
201803 0.000 102.917 0.000
201806 11.625 104.017 14.281
201809 12.248 104.718 14.945
201812 12.791 104.217 15.683
201903 12.832 104.217 15.733
201906 13.474 105.718 16.286
201909 13.953 106.018 16.817
201912 13.967 105.818 16.866
202003 14.706 105.718 17.775
202006 15.380 106.618 18.433
202009 17.214 105.818 20.787
202012 18.980 105.518 22.984
202103 19.771 107.518 23.497
202106 21.808 108.486 25.686
202109 21.293 109.435 24.862
202112 20.299 110.384 23.498
202203 22.981 113.968 25.766
202206 23.531 115.760 25.974
202209 24.415 118.818 26.256
202212 28.151 119.345 30.140
202303 28.116 122.402 29.351
202306 30.205 123.140 31.343
202309 30.046 124.195 30.913
202312 31.219 123.773 32.230
202403 42.798 125.038 43.736
202406 43.023 125.882 43.672
202409 44.509 126.198 45.067
202412 42.903 127.041 43.152
202503 44.140 127.779 44.140

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius Stedim Biotech  (OTCPK:SDMHF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa, 15% from Asia excluding China, and 8% from China.